Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK, and PD of HX15001 in Healthy Volunteers
NCT06999720Phase 1Recruiting
- Sponsor
- Helixon
- Start
- Jun 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of HX15001 (4 arms), sponsored by Helixon. Primary endpoint: Adverse Events (AEs) and Serious Adverse Events (SAEs) at Day 183. Started Jun 2025; status: recruiting.
02
Drugs
HX15001
Beyond the preview
Go deeper on NCT06999720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06999720.